Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriele Fragasso

Showing results (21-30 of 120) with videos related to

Pageof 12
Sort By:
Giornale Italiano Di Cardiologia (2006)|November 27, 2014
[The SIGNIFY study]Salvatore Pirelli, Giorgio Caretta, Gabriele Fragasso
European Heart Journal. Case Reports|October 15, 2021
Case report of cardiogenic shock in COVID-19 myocarditis: peculiarities on diagnosis, histology, and treatmentGiorgio Fiore, Francesca Sanvito, Gabriele Fragasso, et al.
The American Journal of Cardiology|August 26, 2006
Metabolic therapy for patients with diabetes mellitus and coronary artery diseaseGiuseppe M C Rosano, Cristiana Vitale, Gabriele Fragasso
Current Clinical Pharmacology|August 12, 2008
Modulation of fatty acids oxidation in heart failure by selective pharmacological inhibition of 3-ketoacyl coenzyme-A thiolaseGabriele Fragasso, Roberto Spoladore, Amarild Cuko, et al.
Trends in Cardiovascular Medicine|August 21, 2018
Metabolic effects of cardiovascular drugsGabriele Fragasso, Alberto Margonato, Roberto Spoladore, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|July 1, 2014
Hypertrophic cardiomyopathy secondary to hepatitis C virus-related vasculitisGiulio Cavalli, Alvise Berti, Gabriele Fragasso, et al.
Heart, Lung and Vessels|October 24, 2015
Oral direct thrombin inhibition: a double-edged sword?Gabriele Fragasso, Angelo Corti, Ferdinando Loiacono, et al.
Anadolu Kardiyoloji Dergisi : AKD = the Anatolian Journal of Cardiology|December 18, 2012
Myocardial 99m-Tc tetrofosmin reverse redistribution as a possible marker of tissue at riskAnna Salerno, Gabriele Fragasso, Francesco Maranta, et al.
Current Pharmaceutical Design|March 12, 2009
Effects of metabolic approach in diabetic patients with coronary artery diseaseGabriele Fragasso, Anna Salerno, Roberto Spoladore, et al.
Heart and Vessels|September 29, 2009
Cardiotoxicity after low-dose chloroquine antimalarial therapyGabriele Fragasso, Francesca Sanvito, Francesca Baratto, et al.
Pageof 12

Showing results (21-30 of 120) with videos related to

Sort By:
Pageof 12
Giornale Italiano Di Cardiologia (2006)|November 27, 2014
[The SIGNIFY study]Salvatore Pirelli, Giorgio Caretta, Gabriele Fragasso
European Heart Journal. Case Reports|October 15, 2021
Case report of cardiogenic shock in COVID-19 myocarditis: peculiarities on diagnosis, histology, and treatmentGiorgio Fiore, Francesca Sanvito, Gabriele Fragasso, et al.
The American Journal of Cardiology|August 26, 2006
Metabolic therapy for patients with diabetes mellitus and coronary artery diseaseGiuseppe M C Rosano, Cristiana Vitale, Gabriele Fragasso
Current Clinical Pharmacology|August 12, 2008
Modulation of fatty acids oxidation in heart failure by selective pharmacological inhibition of 3-ketoacyl coenzyme-A thiolaseGabriele Fragasso, Roberto Spoladore, Amarild Cuko, et al.
Trends in Cardiovascular Medicine|August 21, 2018
Metabolic effects of cardiovascular drugsGabriele Fragasso, Alberto Margonato, Roberto Spoladore, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|July 1, 2014
Hypertrophic cardiomyopathy secondary to hepatitis C virus-related vasculitisGiulio Cavalli, Alvise Berti, Gabriele Fragasso, et al.
Heart, Lung and Vessels|October 24, 2015
Oral direct thrombin inhibition: a double-edged sword?Gabriele Fragasso, Angelo Corti, Ferdinando Loiacono, et al.
Anadolu Kardiyoloji Dergisi : AKD = the Anatolian Journal of Cardiology|December 18, 2012
Myocardial 99m-Tc tetrofosmin reverse redistribution as a possible marker of tissue at riskAnna Salerno, Gabriele Fragasso, Francesco Maranta, et al.
Current Pharmaceutical Design|March 12, 2009
Effects of metabolic approach in diabetic patients with coronary artery diseaseGabriele Fragasso, Anna Salerno, Roberto Spoladore, et al.
Heart and Vessels|September 29, 2009
Cardiotoxicity after low-dose chloroquine antimalarial therapyGabriele Fragasso, Francesca Sanvito, Francesca Baratto, et al.
Pageof 12